These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 650155)

  • 1. Anti-viral activity induced by culturing lymphocytes with tumor-derived or virus-transformed cells. Identification of the anti-viral activity as interferon and characterization of the human effector lymphocyte subpopulation.
    Trinchieri G; Santoli D; Dee RR; Knowles BB
    J Exp Med; 1978 May; 147(5):1299-1313. PubMed ID: 650155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-viral activity induced by culturing lymphocytes with tumor-derived or virus-transformed cells. Enhancement of human natural killer cell activity by interferon and antagonistic inhibition of susceptibility of target cells to lysis.
    Trinchieri G; Santoli D
    J Exp Med; 1978 May; 147(5):1314-33. PubMed ID: 650156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human tumor necrosis factor produced by human B-cell lines: synergistic cytotoxic interaction with human interferon.
    Williamson BD; Carswell EA; Rubin BY; Prendergast JS; Old LJ
    Proc Natl Acad Sci U S A; 1983 Sep; 80(17):5397-401. PubMed ID: 6193516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody-dependent cellular cytotoxicity effector cells lack Ia antigens.
    Nelson DL; Sachs DH; Dickler HB
    J Immunol; 1977 Sep; 119(3):1034-40. PubMed ID: 330744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The production of vesicular stomatitis virus by antigen- or mitogen-stimulated lymphocytes and continuous lymphoblastoid lines.
    Nowakowski M; Feldman JD; Kano S; Bloom BR
    J Exp Med; 1973 Apr; 137(4):1042-59. PubMed ID: 4348276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiviral and anticellular effects of interferon on the mouse embryonic cells transformed by viruses and/or chemical carcinogen.
    Hajnická V; Borecký L
    Acta Biol Med Ger; 1979; 38(5-6):821-7. PubMed ID: 230678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sensitivity of the Epstein-Barr virus transformed human lymphoid cell lines to interferon.
    Adams A; Strander H; Cantell K
    J Gen Virol; 1975 Aug; 28(2):207-17. PubMed ID: 170370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon as a mediator of human lymphocyte suppression.
    Kadish AS; Tansey FA; Yu GS; Doyle AT; Bloom BR
    J Exp Med; 1980 Mar; 151(3):637-50. PubMed ID: 6444662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immunologic protection against Epstein-Barr virus induced oncogenesis: cooperative effect of lymphocytes, antibodies and interferon in healthy individuals (author's transl)].
    Aya T
    Hokkaido Igaku Zasshi; 1981 Nov; 56(6):587-96. PubMed ID: 6175556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential efficacies of human type I and type II interferons as antiviral and antiproliferative agents.
    Rubin BY; Gupta SL
    Proc Natl Acad Sci U S A; 1980 Oct; 77(10):5928-32. PubMed ID: 6160587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Channel catfish reovirus (CRV) inhibits replication of channel catfish herpesvirus (CCV) by two distinct mechanisms: viral interference and induction of an anti-viral factor.
    Chinchar VG; Logue O; Antao A; Chinchar GD
    Dis Aquat Organ; 1998 Jun; 33(2):77-85. PubMed ID: 9722405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transforming activity and antigenicity of an Epstein-Barr-like virus from lymphoblastoid cell lines of baboons with lymphoid disease.
    Rabin H; Neubauer RH; Hopkins RF; Dzhikidze EK; Shevtsova ZV; Lapin BA
    Intervirology; 1977; 8(4):240-9. PubMed ID: 194867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-immunoglobulin inhibits DNA synthesis in Epstein-Barr virus-transformed lymphoblastoid cell lines.
    Gordon J; Melamed MD; Ley SC; Hughes-Jones NC
    Immunology; 1984 May; 52(1):79-85. PubMed ID: 6325331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transforming activity of Epstein-Barr virus obtained by superinfection of Raji cells.
    Yajima Y; Marczynska B; Nonoyama M
    Proc Natl Acad Sci U S A; 1978 Apr; 75(4):2008-10. PubMed ID: 205877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNAs in virus-induced tumorigenesis and IFN system.
    Fiorucci G; Chiantore MV; Mangino G; Romeo G
    Cytokine Growth Factor Rev; 2015 Apr; 26(2):183-94. PubMed ID: 25466647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human peripheral null lymphocytes. II. Producers of type-1 interferon upon stimulation with tumor cells, Herpes simplex virus and Corynebacterium parvum.
    Peter HH; Dallügge H; Zawatzky R; Euler S; Leibold W; Kirchner H
    Eur J Immunol; 1980 Jul; 10(7):547-55. PubMed ID: 6157543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic production of defective-interfering particles by hamster embryo cultures of herpesvirus persistently infected and oncogenically transformed cells.
    Dauenhauer SA; Robinson RA; O'Callaghan DJ
    J Gen Virol; 1982 May; 60(Pt 1):1-14. PubMed ID: 6178795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of the primary in vitro antibody response by interferon preparations.
    Johnson HM; Smith BG; Baron S
    J Immunol; 1975 Jan; 114(1 Pt 2):403-9. PubMed ID: 1090660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional activity in vivo of effector T cell populations. III. Protection against Moloney murine sarcoma virus (M-MSV)-induced tumors in T cell deficient mice by the adoptive transfer of a M-MSV-specific cytolytic T lymphocyte clone.
    Cerundolo V; Lahaye T; Horvath C; Zanovello P; Collavo D; Engers HD
    Eur J Immunol; 1987 Feb; 17(2):173-8. PubMed ID: 3030766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adult T-cell leukemia-derived factor/thioredoxin, produced by both human T-lymphotropic virus type I- and Epstein-Barr virus-transformed lymphocytes, acts as an autocrine growth factor and synergizes with interleukin 1 and interleukin 2.
    Wakasugi N; Tagaya Y; Wakasugi H; Mitsui A; Maeda M; Yodoi J; Tursz T
    Proc Natl Acad Sci U S A; 1990 Nov; 87(21):8282-6. PubMed ID: 2172979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.